Ligand Pharmaceuticals Inc. (LGND)
Market Closed
16 Oct, 08:00 PM
$
295. 54
-2.96
-0.9916%
$
6.05B Market Cap
23.93 P/E Ratio
- Div Yield
164,503 Volume
4.45 Eps
$ 298.5
Previous Close 
Want to track LGND and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ligand Pharmaceuticals Inc. (LGND) Statistics
Valuation metrics
Market Cap 6.05B
Enterprise value 6.02B
Trailing P/E (ttm) 29.52
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 20.28
Price/Book (mrq) 6.13
Enterprise Value/Revenue 20.71
Enterprise Value/EBITDA 21.96
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 240.35K
Average volume (90 days) 249.84K
Price summary
52-Week low 175.89
52-Week high 326.63
Beta -
50-Day moving average 294.01
200-Day moving average 268.56
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 19 Apr 2007
Ex-Dividend Date 3 Apr 2007
Last split factor 1,603:1,000
Last split Date 2 Nov 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.68%
Operating margin 0.35%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 14.48
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 9.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 67.67
Total debt (mrq) -
Total Debt/Equity (mrq) 1.17
Current ratio (mrq) 31.18%
Book value per share (mrq) 48.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
